Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Ozempic Settles the Obesity Debate: It's Biology Over Willpower
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
Demand for Obesity Drugs Has Insurers Paying Close Attention
Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link
UnitedHealth First-Quarter Earnings, Revenue Up as Company Added Members
Business Earnings Company sees moderate health spending, but higher costs for drugs such as Ozempic Source link
They Took This Drug to Fight Aging. But Does It Actually Work?
An antiaging crowd latched onto the diabetes drug metformin hoping it would extend lifespan. Studies give conflicting results. Source link
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link
The 'King Kong' of Weight-Loss Drugs Is Coming
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but
Americans to Be Barred From Buying Ozempic in British Columbia
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose weight. Source link